Shanghai Yike Completes Tens of Millions of RMB Series B Financing to Accelerate Domestic Substitution of Core Upstream Materials in Medical Devices

VCBeat (WeChat: vcbeat) learned第一时间 that recently, ECO Polymer (Shanghai Yike Polymer Technology Co., Ltd.) has completed a multi-million yuan B round of financing, exclusively invested by Qiming Venture Partners. The funds will be used to further develop medical dialysis membranes and high-end catheters. ECO Polymer will continue to adhere to innovation in China-produced products and break the pattern of imported monopolies.

ECO Polymer was founded in 2020 and is committed to becoming a leading global high-end medical consumables company. The company's headquarters is located in the Zhangjiang High-Tech Park in Shanghai, with a technology research and development center covering thousands of square meters established in Lingang, Shanghai. It also possesses Class 10,000 cleanroom factories totaling nearly ten thousand square meters in both Zhangjiang and Taizhou, Zhejiang.

In the field of medical membrane materials, the company focuses on renal dialysis membranes, pharmaceutical separation membranes, and more. The company has developed a new generation of renal dialysis membranes, and has already reached cooperation intentions with multiple dialyzer clients. It is also fully prepared for the mass production of high-flux membranes.

In the field of medical catheters, the company provides R&D and production services to the medical device industry, focusing on multiple departments such as gastroenterology, cardiovascular and peripheral, neurointerventional, urology, and IVD testing. Core products include neuro and peripheral microcatheters, disposable endoscope catheters, and more. With solid quality and excellent performance, the company's products have entered the global supply chain lists of several world-renowned medical device manufacturers.

Founder of ECO Polymer, Wu JieExpressed: "Thank you to our investors for their trust and support. As a leader and practitioner in China's high-end medical consumables industry, since its establishment in 2021, ECO Polymer has adhered to the mission of 'Professionalism stems from focused efforts, and innovation arises from subtle details,' insisting on innovation as the foundation and quality as the cornerstone, driven by R&D and technical services. Our core business has always revolved around medical tubing, and we have continuously increased R&D investment in the field of medical membrane materials, achieving phased results. In the future, ECO Polymer will continue to uphold our original entrepreneurial vision, constantly solidify, iterate, and innovate our products, providing the driving force for the rapid development of the medical device industry and contributing to Healthy China 2030."

Xubo Hu, Managing Partner of Qiming Venture Partners"It is noted that the technology barrier for renal dialysis membranes is high, and the application of domestically produced renal dialysis membranes will effectively help reduce medical costs. We will continue to strongly support ECO Polymer in developing core technologies, improving product performance, and helping to reduce medical costs."

Qiming Venture Partners, founded in 2006, has successively established offices in Shanghai, Beijing, Suzhou, Hong Kong, China, Seattle, Boston, and the San Francisco Bay Area. Currently, Qiming Venture Partners manages ten U.S. dollar funds and six RMB funds, with total managed assets exceeding $6.2 billion. Since its establishment, it has focused on investing in outstanding early-stage and growth-stage companies in the TMT and healthcare industries. To date, Qiming Venture Partners has invested in more than 430 rapidly growing innovative enterprises, of which over 170 have gone public or exited through mergers and acquisitions on exchanges such as the New York Stock Exchange, NASDAQ, the Hong Kong Stock Exchange, Taiwan's GreTai Securities Market, the Shanghai Stock Exchange, and the Shenzhen Stock Exchange. More than 40 of these enterprises have become unicorns or super unicorns recognized within their respective industries.